Atlantic Union, Sandy Spring announces regulatory approval for acquisition
[ad_1]
Atlantic Union, Sandy Spring announces regulatory approval for acquisition
[ad_2]
[ad_1] JPMorgan files two lawsuits related to Greek fintech Viva Wallet investment – report [ad_2]
[ad_1] SocGen sees sign of bonds becoming more attractive to hold vs. stocks [ad_2]
[ad_1] Twelve more firms settle with SEC on recordkeeping failures over messaging apps [ad_2]
[ad_1] Denali ALS candidate fails in key study [ad_2]
[ad_1] Applied Digital stock jumps on report Macquarie investing up to $5B [ad_2]
[ad_1] Juanmonino/E+ via Getty Images InflaRx (NASDAQ:IFRX) has received EU regulatory approval for its treatment Gohibic for the treatment of COVID-19 patients experiencing acute respiratory distress. The European Commission granted marketing authorization under exceptional circumstances for Gohibic, also known as vilobelimab, for the treatment of adult patients [ad_2]